| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |